# Dynavax GmbH – FDA Inspection, Feb 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/dynavax-gmbh/a6b7915e-591e-4487-b624-a2b74eb6493b
Source feed: FDA_Inspections

> FDA inspection 1201864 of Dynavax GmbH, February 03, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201864
- Company Name: Dynavax GmbH
- Inspection Date: 2023-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1084951 - 2019-03-05](https://www.keypedia.com/records/fda_inspections/dynavax-gmbh/a8c35179-518c-40c2-aeb5-638214eaf10b)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/dynavax-gmbh/3c69b2a7-44b1-4674-8038-963c355c138f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
